click below
click below
Normal Size Small Size show me how
pancreas
ch 18 therapeutic agents for the endocrine system, pharm tech
Question | Answer |
---|---|
pancreas | responsible for insulin and glucagon production and release |
insulin | important to transportation of glucose in the cell |
diabetes mellitus | chronic endocrine disease associated with hyperglycemia - blood glucose increase; too much sugar in the blood (high blood glucose). |
Type 1 diabetes mellitus | T1DM; inability of pancreas to synthesize and secrete insulin leading to insulin deficiency; absolute deficiency of insulin |
symptoms of T1DM | polyuria (frequent urination), polydipsia (excessive thirst), and polyphagia (excessive appetite); glucose loss via urination can cause dehydration, weight loss, fatigue, and extreme hunger |
Type 2 diabetes mellitus | insulin resistance, decreased ability of tissues to respond to insulin |
risk factors for T2DM | obesity, lack of exercise, HBP, history of GDM, older than 45, family history of T2DM, hyperlipidemia (elevated cholesterol levels) |
GDM | gestational diabetes; occurs during pregnancy and ususally returns to normal following birth |
rapid acting insulin (within 15 min and lasts 4-6 hrs) | Humalog/insulin lispro, Novolog/insulin aspart, Apidra/insulin glulisine |
short acting insulin (within 1 hr and lasts 6-10 hrs) | Humulin R, and Novolin R (all generically known as regular human insulin) |
intermediate-acting insulin products (within 2 hrs and lasts 10-16 hrs) | Humulin N / NPH insulin; Novolin N |
long acting insulin (within 3-4 hrs and lasts 14-24 hours) | Levemir or Levemir FlexPen / insulin detemir |
long acting insulin (within 2-4 hrs and lasts up to 24 hrs) | Lantus or Lantus Solostar / insulin glargine |